COMMUNIQUÉS West-GlobeNewswire

Las Vegas Tech Company Launches Downtown Coworking Space Cannabis Business Den
04/09/2019
LAS VEGAS, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Cannabis Business Den, a new coworking, meeting, event, and interactive showroom space for cannabis industry professionals, is the latest addition to the revitalized [...]
JDRF Brings Together Hamilton Community, Researcher, and Elected Officials to Discuss Affordable Access to Life-Changing Technologies for type 1 diabetes
04/09/2019
HAMILTON, Ontario, Sept. 04, 2019 (GLOBE NEWSWIRE) -- On Wednesday, September 11, JDRF Canada will host a community forum to address the need for access to affordable type 1 diabetes (T1D) technologies for the more than [...]
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
04/09/2019
NeuLiv ™ is the Third Drug Development Program From Company’s DN-TNF Platform Presentation is Scheduled for 2.10 p.m. on Sept. 9 th LA JOLLA, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), [...]
Seelos Therapeutics to Participate in Upcoming Investor Conference in September
04/09/2019
Company Will Host Meetings at the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies in NYC NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical- [...]
Chiesi and Durham Bulls Partnership Culminates in $15,000 to Triangle Nonprofits
04/09/2019
Partnership hits a grand slam for local youth charities as the 2019 presenting strikeouts sponsor CARY, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- As the Durham Bulls faced off against the Gwinnett Stripers on August 31, [...]
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
04/09/2019
LAVAL, Québec, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
04/09/2019
Phase 1b study of DNL151 includes Parkinson’s disease patients with and without a genetic LRRK2 mutation Either DNL151 or DNL201 anticipated to be selected for potential registrational clinical trials in 2020 The Engage [...]
Ozop Surgical Corp. Announces Addition of Spine Industry Veteran to Lead its Sales Team
04/09/2019
Ozop adds Nick Ansari as Executive Vice President of Sales and Marketing WEST PALM BEACH, FL, Sept. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium surgical [...]
American Society for Gastrointestinal Endoscopy Includes WATS3D in Its New Practice Guideline for the Screening and Surveillance of Barrett’s Esophagus
04/09/2019
SUFFERN, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- CDx Diagnostics, developer of the WATS 3D diagnostic platform for the screening and surveillance of Barrett’s esophagus (BE), a known precursor to esophageal cancer (EC [...]
BioNovelus, Inc. Announces Chuck Zingler to Join Advisory Board
04/09/2019
POTOMAC, Md., Sept. 04, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTCMARKETS: ONOV) announces Mr. Chuck Zingler will join the Company’s newly created Advisory Board. BioNovelus’ Advisory Board seats individual [...]
Revenue Maximization Group Recognized by CIO Applications Magazine as Top 25 Healthcare Solutions Provider
04/09/2019
Newly Acquired Division of Nexteligent Holdings, Inc. Delivers Revenue Cycle Management and Preventative Wellness Services LAS VEGAS, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Nexteligent Holdings, Inc. f/k/a Efftec [...]
30,000 Canadian Businesses to Benefit from Teladoc Telemedicine Services
04/09/2019
Employees of small- to mid-size companies to have faster access to medical care TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today its partnership [...]
Les Services de télémédecine de Teladoc bénéficieront à 30 000 entreprises canadiennes
04/09/2019
Un accès plus rapide à des soins médicaux pour les employés des petites et moyennes entreprises TORONTO, 04 sept. 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE : TDOC), le chef de file mondial de solutions virtuelles de [...]
30,000 Canadian Businesses to Benefit from Teladoc Telemedicine Services
04/09/2019
Employees of small- to mid-size companies to have faster access to medical care TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today its partnership [...]
Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
04/09/2019
WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief [...]
Noblegen Adds Two Top Industry Executives to its Board of Directors
04/09/2019
Former General Mills EVP of Innovation Technology and Quality, Peter Erickson, and current VP & CFO of JRSL Don Solman join Noblegen’s Board of Directors PETERBOROUGH, Ontario, Sept. 04, 2019 (GLOBE NEWSWIRE) -- [...]
Checkpoint Therapeutics to Present at September 2019 Investor Conferences
04/09/2019
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
04/09/2019
BERKELEY, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) [...]
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference
04/09/2019
EDISON, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]

Pages